Back to search

Article

Decoding WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer to Inform Precision Oncology

2025-12-23

Abstract excerpt

Early-onset colorectal cancer (EOCRC) is rising most rapidly among Hispanic/Latino (H/L) populations, yet the prognostic relevance of WNT pathway alterations under contemporary therapies remains unclear. We conducted a multi-cohort analysis integrating somatic genomics with clinical and treatment annotations (including bevacizumab exposure) from public CRC datasets, stratifying by age of onset and ancestry (H/L vs...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff5eb759-4bf2-5659-95b7-1cee24dbf778
DOI
10.64898/2025.12.22.25342868
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Decoding WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer to Inform Precision OncologyDOI 10.64898/2025.12.22.25342868
Select a neighboring publication to make it the new centre.